104 related articles for article (PubMed ID: 10149537)
1. Biocompatibility of extracorporeal immunoadsorption systems.
Kadar JG; Borberg H
Transfus Sci; 1990; 11(2):223-39. PubMed ID: 10149537
[TBL] [Abstract][Full Text] [Related]
2. Protein A tangential flow affinity membrane cartridge for extracorporeal immunoadsorption therapy.
Jia L; Yang L; Zou H; Zhang Y; Zhao J; Fan C; Sha L
Biomed Chromatogr; 1999 Nov; 13(7):472-7. PubMed ID: 10534759
[TBL] [Abstract][Full Text] [Related]
3. Plasmapheresis and immunoadsorption: different techniques and their current role in medical therapy.
Schneider KM
Kidney Int Suppl; 1998 Feb; 64():S61-5. PubMed ID: 9475492
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic immunoadsorption--its role in clinical practice.
Braun N; Kadar JG; Risler T
Transfus Sci; 1998 Mar; 19 Suppl():65-9. PubMed ID: 10178698
[TBL] [Abstract][Full Text] [Related]
5. Quo vadis haemapheresis. Current developments in haemapheresis.
Borberg H
Transfus Apher Sci; 2006 Feb; 34(1):51-73. PubMed ID: 16412691
[TBL] [Abstract][Full Text] [Related]
6. Technical and clinical experience with protein A immunoadsorption columns.
Belàk M; Borberg H; Jimenez C; Oette K
Transfus Sci; 1994 Dec; 15(4):419-22. PubMed ID: 10155559
[TBL] [Abstract][Full Text] [Related]
7. [The clinical use of immunosorption: problems and perspectives].
Chuchalin AG; Lebedin IuS; Raudla LA
Vestn Akad Med Nauk SSSR; 1990; (3):44-8. PubMed ID: 2191512
[TBL] [Abstract][Full Text] [Related]
8. Staphylococcus protein A-based extracorporeal immunoadsorption and thalidomide in the treatment of skin manifestation of dermatomyositis: a case report.
Sebastiani M; Puccini R; Manfredi A; Manni E; Colaci M; Mattei P; Barachini P; Ferri C
Ther Apher Dial; 2009 Jun; 13(3):225-8. PubMed ID: 19527470
[TBL] [Abstract][Full Text] [Related]
9. Improving tumor-to-normal-tissue ratios of antibodies by extracorporeal immunoadsorption based on the avidin-biotin concept: development of a new treatment strategy applied to monoclonal antibodies murine L6 and chimeric BR96.
Tennvall J; Garkavij M; Chen J; Sjögren HO; Strand SE
Cancer; 1997 Dec; 80(12 Suppl):2411-8. PubMed ID: 9406691
[TBL] [Abstract][Full Text] [Related]
10. Extracorporeal immunoadsorption for the treatment of coagulation inhibitors.
Franchini M; Sassi M; Dell'Anna P; Manzato F; Salvagno GL; Montagnana M; Zaffanello M; Targher G; Lippi G
Semin Thromb Hemost; 2009 Feb; 35(1):76-80. PubMed ID: 19308895
[TBL] [Abstract][Full Text] [Related]
11. [The clinical use of protein-A immunoadsorption].
Aksenov VA
Ter Arkh; 1996; 68(11):83-5. PubMed ID: 9045392
[No Abstract] [Full Text] [Related]
12. [Development of a technique of immunoadsorption of LDL-cholesterol].
Regnault V; Rivat C; Schooneman F; Marcillier P; Michaely JP; Didelon J; Stoltz JF; Siadat M
Ann Med Interne (Paris); 1990; 141(7):604-7. PubMed ID: 2085239
[TBL] [Abstract][Full Text] [Related]
13. Treatment of autoimmune disease by immunomodulation through extracorporeal elimination and intravenous immunoglobulin.
Borberg H; Jimenez C; Belàk M; Haupt WF; Späth P
Transfus Sci; 1994 Dec; 15(4):409-18. PubMed ID: 10155558
[TBL] [Abstract][Full Text] [Related]
14. A new device for specific extracorporeal immunoadsorption of anti-DNA antibodies. In vitro and in vivo results.
Traeger J; Laville M; Serres PF; Cronenberger M; Thomas M; Rey MJ; Bourgeat C
Ann Med Interne (Paris); 1992; 143 Suppl 1():9-12. PubMed ID: 1300896
[TBL] [Abstract][Full Text] [Related]
15. Remission of demyelinating polyneuropathy with immunoadsorption, low dose corticosteroids and anti-CD20 monoclonal antibody.
Rech J; Hueber AJ; Kallert S; Leipe J; Kalden JR; Beck M; Schett G; Schulze-Koops H
Ther Apher Dial; 2008 Jun; 12(3):205-8. PubMed ID: 18503697
[TBL] [Abstract][Full Text] [Related]
16. [Immunoadsorption therapy for myasthenia gravis: study on the adsorption capacity of an immunoadsorption column].
Yeh JH; Chiu HC
J Microbiol Immunol Infect; 1999 Jun; 32(2):121-5. PubMed ID: 11565565
[TBL] [Abstract][Full Text] [Related]
17. Membranes and polymer structures--biocompatibility aspects with respect to production limits.
Ansorge W; Spindler E; Vienken J; Baurmeister U
Transfus Sci; 1993 Apr; 14(2):199-209. PubMed ID: 10148613
[TBL] [Abstract][Full Text] [Related]
18. Application of LDL-apheresis and immunoadsorption in kidney diseases.
Sułowicz W; Stompór T
Rocz Akad Med Bialymst; 2004; 49():127-34. PubMed ID: 15631328
[TBL] [Abstract][Full Text] [Related]
19. Increased ethyl mercury load in protein a immunoadsorption.
Marn-Pernat A; Buturović-Ponikvar J; Logar M; Horvat M; Ponikvar R
Ther Apher Dial; 2005 Jun; 9(3):254-7. PubMed ID: 15967001
[TBL] [Abstract][Full Text] [Related]
20. Plasmapheresis-immunoadsorption for treatment of systemic lupus erythematosus in a dog.
Matus RE; Scott RC; Saal S; Gordon BR; Hurvitz AI
J Am Vet Med Assoc; 1983 Mar; 182(5):499-502. PubMed ID: 6339455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
